DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🔴 Decoy Therapeutics is trading 5% down today in pre-market with no clear catalyst identified
Decoy Therapeutics is trading at $2.82 (-5.37%), with no clear catalyst identified. - No new company-specific announcement, filing, earnings release, or major...
🔴 Decoy Therapeutics is trading 5% down in pre-market with no clear catalyst identified
Decoy Therapeutics is trading 5.23% down at $2.90 after no clear company-specific announcement, filing, earnings release, or major event was identified for...
🟢 Decoy Therapeutics is trading 7.44% up today with no clear catalyst identified
Decoy Therapeutics is trading 7.44% up at $3.28 after opening higher on September 1, 2026, with no clear reason for the move. - No clear company-specific...
🟢 Decoy Therapeutics is trading 5.47% up today with no clear catalyst identified
Decoy Therapeutics is trading at $3.06, up +5.47%, with no clear catalyst identified. - No company-specific announcement, filing, earnings release, or major...
🟢 Decoy Therapeutics is trading 10.34% up in pre-market with no clear catalyst identified
Decoy Therapeutics is trading 10.34% up at $3.20, versus the August 28 close of $2.90, with no clear company-specific catalyst identified. - No clear...
🟢 Decoy Therapeutics is trading 8.89% up in pre-market; no clear catalyst identified
Decoy Therapeutics is trading at $3.16, up 8.89%, with no clear company-specific catalyst identified. - No clear August 31, 2026, company-specific...
🟢 Decoy Therapeutics is trading 5.6% up in after-hours trading with no confirmed company-specific catalyst
Decoy Therapeutics is trading at $3.15 (+5.56%) after-hours, most consistent with broader risk-on sentiment and thin extended-hours liquidity. - No verified...
🟢 Decoy Therapeutics is trading 11.25% up in pre-market despite no new company-specific catalyst
Decoy Therapeutics is trading 11.25% up at $3.56 after no new company-specific catalyst was identified for August 24, 2026. - Its latest reported developments...
🔴 Decoy Therapeutics is trading 7.93% down in pre-market — no fresh company-specific catalyst identified
Decoy Therapeutics is trading 7.93% down at $3.02 after falling from the August 20 close of $3.28, with no fresh company-specific catalyst identified. - The...
🟢 Decoy Therapeutics is trading 8.71% up today after successful Phase 3 personalized cancer-vaccine results
Decoy Therapeutics is trading 8.71% up now at $3.71, with the move appearing mainly linked to stronger biotechnology sentiment after Moderna and Merck reported...
🔴 Decoy Therapeutics is trading 5% down today with no clear company-specific catalyst
Decoy Therapeutics is trading $3.48 (-5.18%) lower, with no clear company-specific catalyst identified for August 19, 2026. • Recent Q2 results showed a $2.4...
🔴 Decoy Therapeutics is trading 15.54% down in pre-market without a clear company-specific catalyst
Decoy Therapeutics is trading 15.54% down at $3.10 after no clear company-specific catalyst was identified for August 19, 2026. • Recent Q2 results reported a...
🟢 Decoy Therapeutics is trading 5.4% up today; no clear catalyst identified
Decoy Therapeutics is trading 5.4% up at $3.71, despite broader U.S. markets moving lower on August 18, 2026; the rally’s cause remains unclear. - Searches...
🟢 Decoy Therapeutics is trading 8% up today
Decoy Therapeutics is trading at $3.88, up +8.38%, with no clear catalyst identified. - No new company-specific announcement dated August 17, 2026 was...
Decoy Therapeutics Posts Wider Loss and Warns of Delisting — So Why Is the Stock Up Nearly 9%?
Shares of Decoy Therapeutics (DCOY) shifted higher Thursday, rising 8.8% to $3.84, even as the preclinical-stage biotech disclosed a grim set of second-quarter...
🟢 Decoy Therapeutics is trading 8.8% up in after-hours trading after warning of potential Nasdaq delisting risk
Decoy Therapeutics is trading 8.78% up now at $3.84 after warning its shortened cash runway could create a potential Nasdaq delisting risk. - Reported a $2.37...
Decoy Therapeutics Warns of Potential Delisting, Citing Shortened Cash Runway
Decoy Therapeutics Inc. reported a $2.37 million net loss for the second quarter of 2026. This result represents a significant widening from the previous...
🔴 Decoy Therapeutics is trading 7% down today with no clear catalyst
Decoy Therapeutics is trading 7% down at $3.60, extending recent weakness despite broader U.S. indexes trading higher on August 12, 2026, with the cause...
🟢 Decoy Therapeutics is trading 5.3% up today with no confirmed company-specific catalyst
Decoy Therapeutics is trading 5.3% up at $4.07, with no confirmed company-specific announcement or Q2 earnings release found for August 11, 2026. - The...
Decoy Therapeutics Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Decoy Therapeutics is expected to report a Q2 2026 consensus loss of $2.88 per share on $0 revenue, with the stock currently trading at $3.92, significantly...